MedPath

Obesity: Cesarean Health by Incision Placement

Not Applicable
Conditions
Maternal Morbidity
Interventions
Procedure: Cohen Incision
Registration Number
NCT02909582
Lead Sponsor
Thomas Jefferson University
Brief Summary

Hypothesis: A Pfannenstiel cesarean skin incision placed under the pannus (should a pannus exist) will have a higher maternal morbidity composite rate than a Cohen cesarean skin incision placed above the pannus (should a pannus exist).

Detailed Description

Introduction: Obesity affects approximately 1/3rd of all reproductive-aged women and is associated with increased maternal morbidity during and after cesarean section. The optimal surgical approach has not been well elucidated for obese individuals.

Materials and Methods: This is a randomized controlled trial comparing a Pfannenstiel incision placed below the pannus (should a pannus exist) with a Cohen incision placed above the pannus (should a pannus exist); allocation is 1:1 with stratification for pre-gestational diabetes and presence of pannus. The study will be assessed by intention-to-treat analysis looking composite maternal morbidity (wound complications within 6 weeks, endometritis, postpartum hemorrhage) as the primary outcome with secondary outcomes including wound complications, operative time, estimated blood loss, pain management, and patient and surgeon satisfaction. Significant confounders will be assessed and adjusted in the multiple regression analysis accordingly.

Results: The investigators propose the Cohen cesarean incision will result in statistically less maternal morbidity from cesarean section than the Pfannenstiel incision.

Comment: The benefits of a Cohen incision have been encouraged in non-obese pregnant women; the investigators propose that they be considered in obese women as well.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
284
Inclusion Criteria
  • BMI > or = 35 kg/m2 at time of presentation for delivery
  • Speaks English
Exclusion Criteria
  • BMI < 35 kg/m2 at time of presentation or delivery
  • Unable to consent (including language spoken other than English)
  • Prior abdominal incisions or obstetric factors necessitating placement of incision in specified location, at the discretion of the attending surgeon
  • Infection present (ie cellulitis) precluding incision placement at one of the randomization sites

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cohen IncisionCohen IncisionThis is a straight transverse incision through the skin, 3 cm below the level of the anterior superior iliac spines (higher than the Pfannenstiel incision). Should a pannus exist, the pannus should be left in the physiologic location (not retracted) to allow placement of the incision.
Primary Outcome Measures
NameTimeMethod
Composite Maternal Morbidity18 months

To compare composite maternal morbidity (wound complications within 6 weeks including cellulitis, wound abscess, wound separation or dehiscence, hematoma, seroma formation, endometritis, postpartum hemorrhage), by placement type of transverse Cesarean skin incision in individuals with BMI \>35 kg/m2.

Secondary Outcome Measures
NameTimeMethod
Attending surgeon satisfaction (on 1-10 Likert scale) with feasibility of surgery by incision type18 months
Composite maternal morbidity (as above) by stage of pannus18 months
Composite wound complication rates (cellulitis, wound abscess, wound separation or dehiscence, hematoma, seroma)18 months
Length in minutes of total operating time (from time of skin incision to the completion of closure of the skin incision)18 months
Estimated blood loss (in milliliters)18 months
Patient satisfaction (via two questions, Likert scale)18 months
Incidence of low transverse uterine incisions (hysterotomy) with all other types of uterine incisions (vertical, high transverse, etc).18 months
Length in minutes of operative time from time of skin incision to time of delivery of the neonate18 months
Severity of pain (via Likert scale) and amount of pain medications utilized in the first 48 hours post procedure18 months

Trial Locations

Locations (1)

Thomas Jefferson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath